Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionArrowMark Colorado Holdings LLC
Latest Disclosed Ownership1,374,103 shares
Latest Disclosed Value $ 44,259,858
ArrowMark Colorado Holdings LLC reports 12.00% decrease in ownership of 12V / Veracyte, Inc.

On May 15, 2026 - ArrowMark Colorado Holdings LLC filed a 13F-HR form disclosing ownership of 1,374,103 shares of Veracyte, Inc. (DE:12V) valued at $36,551,140 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,561,449 shares of Veracyte, Inc.. This represents a change in shares of -12.00% during the quarter. The current value of the position is $55,692,395 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERACYTE COM 92337F107 1,374,103 -187,346 -12.00 44,260 -32.67 1.1764
2026-02-17 2025-12-31 13F VERACYTE COM 92337F107 1,561,449 -984,290 -38.66 65,737 -24.78 1.4465
2025-11-14 2025-09-30 13F VERACYTE COM 92337F107 2,545,739 -33,084 -1.28 87,395 25.38 1.6231
2025-08-14 2025-06-30 13F VERACYTE COM 92337F107 2,578,823 -647,850 -20.08 69,706 -27.14 1.2553
2025-05-15 2025-03-31 13F VERACYTE COM 92337F107 3,226,673 146,646 4.76 95,671 -21.56 1.5494
2025-02-14 2024-12-31 13F VERACYTE COM 92337F107 3,080,027 97,824 3.28 121,969 20.15 1.6403
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 2,982,203 -15,580 -0.52 101,514 56.27 1.3003
2024-08-14 2024-06-30 13F VERACYTE COM 92337F107 2,997,783 354,538 13.41 64,962 10.90 0.7746
2024-05-15 2024-03-31 13F VERACYTE COM 92337F107 2,643,245 126,105 5.01 58,574 -15.41 0.6578
2024-02-14 2023-12-31 13F VERACYTE COM 92337F107 2,517,140 206,281 8.93 69,247 34.20 0.7643
2023-11-14 2023-09-30 13F VERACYTE COM 92337F107 2,310,859 -80,120 -3.35 51,601 -15.27 0.6279
2023-08-14 2023-06-30 13F VERACYTE COM 92337F107 2,390,979 178,414 8.06 60,898 23.43 0.6683
2023-05-15 2023-03-31 13F VERACYTE COM 92337F107 2,212,565 -577,105 -20.69 49,340 -25.47 0.5607
2023-02-14 2022-12-31 13F VERACYTE COM 92337F107 2,789,670 -59,750 -2.10 66,199 39.95 0.7902
2022-11-14 2022-09-30 13F VERACYTE COM 92337F107 2,849,420 -852,556 -23.03 47,300 -35.79 0.5801
2022-08-15 2022-06-30 13F VERACYTE COM 92337F107 3,701,976 612,533 19.83 73,669 -13.51 0.8429
2022-05-16 2022-03-31 13F VERACYTE COM 92337F107 3,089,443 562,021 22.24 85,176 -18.20 0.7452
2022-02-14 2021-12-31 13F VERACYTE COM 92337F107 2,527,422 18,172 0.72 104,130 -10.66 0.8348
2021-11-15 2021-09-30 13F VERACYTE COM 92337F107 2,509,250 -23,338 -0.92 116,555 15.11 0.9186
2021-08-16 2021-06-30 13F VERACYTE COM 92337F107 2,532,588 1,008,289 66.15 101,253 23.58 0.7622
2021-05-17 2021-03-31 13F VERACYTE COM 92337F107 1,524,299 735,121 93.15 81,931 112.14 0.6126
2021-02-16 2020-12-31 13F VERACYTE COM 92337F107 789,178 -63,022 -7.40 38,622 39.49 0.2993
2020-11-16 2020-09-30 13F VERACYTE COM 92337F107 852,200 -272,583 -24.23 27,688 -4.96 0.2640
2020-08-14 2020-06-30 13F VERACYTE COM 92337F107 1,124,783 -22 -0.00 29,132 6.54 0.3034
2020-05-15 2020-03-31 13F VERACYTE COM 92337F107 1,124,805 1,124,805 27,344 0.3590
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.